Augmentation of antileishmanial efficacy of miltefosine in combination with tuftsin against experimental visceral leishmaniasis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Parasitology Research

• Publication date

  2012-03-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00436-012-2868-zPMID 22392136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration.

  2015cited by this paper
• Leishmania-macrophage interactions: insights into the redox biology.

  2011cited by this paper
• Combination Therapy with Paromomycin-Associated Stearylamine-Bearing Liposomes Cures Experimental Visceral Leishmaniasis through Th1-Biased Immunomodulation

  2011cited by this paper
• CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.

  2010cited by this paper
• Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent

  2010cited by this paper
• Anti-iL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide.

  2009cited by this paper
• Developments in the treatment of visceral leishmaniasis

  2009cited by this paper
• New Treatment Option for Second-Stage African Sleeping Sickness: In Vitro and In Vivo Efficacy of Aza Analogs of DB289

  2009cited by this paper
• Drug Resistance in Visceral Leishmaniasis

  2009cited by this paper
• Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example

  2008cited by this paper
• Tuftsyna - nowe analogi i wlasciwosci

  2007cited by this paper
• Induction of Host Protective Th1 Immune Response by Chemokines in Leishmania donovani‐infected BALB/c Mice

  2007cited by this paper
• [Tuftsin--new analogues and properties].

  2007cited by this paper
• In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs

  2006cited by this paper
• Efficacy of picroliv in combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis.

  2005cited by this paper
• Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations.

  2004cited by this paper
• Ascorbate‐mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide

  2004cited by this paper
• A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells.

  2001cited by this paper
• Tuftsin-bearing liposomes in treatment of macrophage-based infections.

  2000cited by this paper
• The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro

  1994cited by this paper
• Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases

  1992cited by this paper
• The immune dependence of chemotherapy.

  1991cited by this paper
• Drug targeting in Leishmania donovani infections using tuftsin‐bearing liposomes as drug vehicles

  1989cited by this paper
• Tuftsin: its chemistry, biology, and clinical potential.

  1989cited by this paper
• Tuftsin induced tumor necrosis activity

  1987cited by this paper
• Specific interactions of liposomes with PMN leukocytes upon incorporating tuftsin in their bilayers

  1984cited by this paper
• Tuftsin‐macrophage interaction: Specific binding and augmentation of phagocytosis

  1979cited by this paper

• Current and Emerging Pharmacological Treatments for Visceral Leishmaniasis.

  2026cites this paper
• Combination therapy with amphotericin B and Ultradiluted Leishmania donovani antigen skews cytokine balance towards protective immunity in visceral leishmaniasis.

  2026cites this paper
• Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection

  2022cites this paper
• USO DA CITOMETRIA DE FLUXO PARA QUANTIFICAÇÃO DE Leishmania sp. INTRACELULAR

  2022influential citation
• Could combination chemotherapy be more effective than monotherapy in the treatment of visceral leishmaniasis? A systematic review of preclinical evidence

  2022cites this paper
• Targeted Drug Delivery Using Tuftsin-bearing Liposomes: Implications in the treatment of infectious diseases and tumors.

  2020cites this paper
• Systematic Review of Host-Mediated Activity of Miltefosine in Leishmaniasis through Immunomodulation

  2019cites this paper
• Tuftsin - Properties and Analogs.

  2017cites this paper
• Chemical and biological properties of a supramolecular complex of tuftsin and cucurbit[7]uril

  2017cites this paper
• Surface-Modified Liposomal Formulation of Amphotericin B: In vitro Evaluation of Potential Against Visceral Leishmaniasis

  2016cites this paper
• Treatment of leishmaniasis: a review and assessment of recent research.

  2015cites this paper
• Epidemiological studies on zoonotic leishmaniasis and new trials for studying the effect of melatonin on the parasite

  2015cites this paper
• Plasmodium falciparum malaria and invasive bacterial co-infection in young African children: the dysfunctional spleen hypothesis

  2014cites this paper
• To investigate the therapeutic potential of immunochemotherapy with cisplatin + 78 kDa + MPL‐A against Leishmania donovani in BALB/c mice

  2014cites this paper
• Evaluation of the effect of miltefosine on Trichomonas vaginalis

  2014cites this paper
• Translating immune cell cross-talk into a treatment opportunity for visceral leishmaniasis.

  2013cites this paper
• Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis

  2012cites this paper